Atossa Therapeutics, Inc. ATOS
NASDAQ · United States · Health Technology
$2.34+0.07 (+3.08%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | -0.95 | -1.03 | +7.3% | $0 | — | -2.1%$2.42→$2.37 |
| Q1 2026 | 2026-05-08 | -1.11 | -0.99 | -12.1% | — | — | -3.0%$5.67→$5.50 |
| Q4 2025 | 2026-03-25 | -1.34 | -1.14 | -17.5% | — | — | -14.5%$5.51→$4.71 |
| Q3 2025 | 2025-11-12 | -1.05 | -1.00 | -5.0% | — | — | -3.6%$12.45→$12.00 |
| Q2 2025 | 2025-08-12 | -1.05 | -0.85 | -23.5% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.75 | -0.82 | +8.5% | — | — | — |
| Q4 2024 | 2025-03-25 | -0.75 | -0.95 | +21.1% | — | — | — |
| Q2 2024 | 2024-08-12 | -0.75 | -0.90 | +16.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.